Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report
encephalitis · 2022
DOI: 10.47936/encephalitis.2021.00108 ↗Kurz gefasst
Fallbericht in der Zeitschrift encephalitis, 2022. Verfasst von Seondeuk Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University Hospital, Seoul, Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Takayasu arteritis (TAK) is a systemic vasculitis involving large arteries. Reports of direct central nervous system (CNS) involvement in TAK are extremely rare in the literature. In addition, treatment for direct involvement has not been reported. Herein, we describe a case of encephali-tis in a TAK patient who presented with fever and headache at the first attack, then cognitive impairment at the second attack. The patient improved with rituximab and especially infliximab. These findings indicate the usefulness of rituximab and infliximab to treat the direct CNS mani-festations in TAK.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Seoul National University Hospital, Seoul, Korea.
- Laboratory for Neurotherapeutics, Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Rare Disease Center, Seoul National University Hospital, Seoul, Korea.
- Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Kon Chu
Zitieren
APA
Kim, S., Ahn, S. J., Lee, H. S., Lee, W. J., Moon, J., Park, J. K., & Chu, K. (2022). Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report. encephalitis. https://doi.org/10.47936/encephalitis.2021.00108
Vancouver
Kim S, Ahn SJ, Lee HS, Lee WJ, Moon J, Park JK, et al. Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report. encephalitis. 2022. doi:10.47936/encephalitis.2021.00108
BibTeX
@article{Kim2022,
author = {Kim, Seondeuk and Ahn, Seon-Jae and Lee, Han Sang and Lee, Woo-Jin and Moon, Jangsup and Park, Jin Kyun and Chu, Kon},
title = {Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report},
journal = {encephalitis},
year = {2022},
doi = {10.47936/encephalitis.2021.00108}
}
EUVIMED